全文获取类型
收费全文 | 54653篇 |
免费 | 4557篇 |
国内免费 | 624篇 |
专业分类
耳鼻咽喉 | 904篇 |
儿科学 | 1042篇 |
妇产科学 | 1012篇 |
基础医学 | 8545篇 |
口腔科学 | 839篇 |
临床医学 | 5166篇 |
内科学 | 10854篇 |
皮肤病学 | 1730篇 |
神经病学 | 4727篇 |
特种医学 | 3050篇 |
外国民族医学 | 4篇 |
外科学 | 6530篇 |
综合类 | 842篇 |
现状与发展 | 2篇 |
一般理论 | 18篇 |
预防医学 | 3394篇 |
眼科学 | 1420篇 |
药学 | 4817篇 |
1篇 | |
中国医学 | 592篇 |
肿瘤学 | 4345篇 |
出版年
2023年 | 268篇 |
2022年 | 592篇 |
2021年 | 1534篇 |
2020年 | 879篇 |
2019年 | 1277篇 |
2018年 | 1427篇 |
2017年 | 1128篇 |
2016年 | 1643篇 |
2015年 | 2153篇 |
2014年 | 2535篇 |
2013年 | 2971篇 |
2012年 | 4221篇 |
2011年 | 4105篇 |
2010年 | 2532篇 |
2009年 | 2113篇 |
2008年 | 2961篇 |
2007年 | 2929篇 |
2006年 | 2615篇 |
2005年 | 2441篇 |
2004年 | 2085篇 |
2003年 | 1843篇 |
2002年 | 1673篇 |
2001年 | 1038篇 |
2000年 | 1000篇 |
1999年 | 889篇 |
1998年 | 423篇 |
1997年 | 396篇 |
1996年 | 333篇 |
1995年 | 331篇 |
1994年 | 269篇 |
1993年 | 274篇 |
1992年 | 622篇 |
1991年 | 637篇 |
1990年 | 555篇 |
1989年 | 612篇 |
1988年 | 607篇 |
1987年 | 583篇 |
1986年 | 508篇 |
1985年 | 516篇 |
1984年 | 397篇 |
1983年 | 327篇 |
1982年 | 245篇 |
1981年 | 225篇 |
1980年 | 203篇 |
1979年 | 302篇 |
1978年 | 257篇 |
1977年 | 181篇 |
1974年 | 203篇 |
1973年 | 219篇 |
1972年 | 174篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Dongbing Lai Emma C. Johnson Sarah Colbert Gayathri Pandey Grace Chan Lance Bauer Meredith W. Francis Victor Hesselbrock Chella Kamarajan John Kramer Weipeng Kuang Sally Kuo Samuel Kuperman Yunlong Liu Vivia McCutcheon Zhiping Pang Martin H. Plawecki Marc Schuckit Jay Tischfield Leah Wetherill Yong Zang Howard J. Edenberg Bernice Porjesz Arpana Agrawal Tatiana Foroud 《Alcoholism, clinical and experimental research》2022,46(3):374-383
2.
目的 通过分析特发性肺纤维化急性加重期(AE-IPF)患者证候与血清生物标志物的关系,为中医辨证治疗提供参考。方法 采用观察性研究设计,收集2019年3月至2019年11月三个中心的AE-IPF患者76例,其中痰热壅肺证26例、痰浊阻肺证50例,并纳入健康志愿者10例作为对照。采用ELISA测定患者血清CCL18、HMGB1、KL-6、MMP-7、SP-A和SP-D水平,分析与中医证候的相关性。结果 AE-IPF患者血清CCL18、HMGB1、KL-6、MMP-7、SP-A和SP-D水平均显著高于健康对照组。血清CCL18、HMGB1、KL-6、MMP-7和SP-D水平在痰热壅肺证和痰浊阻肺证患者间无显著性差异(P>0.05),而血清SP-A水平存在显著性差异(P<0.05)。结论 血清SP-A与AE-IPF证候存在一定的相关性,血清SP-A的浓度升高,与痰热壅肺证关系越密切,反之,血清SP-A浓度降低,则与痰浊阻肺证关系越密切。AE-IPF痰热壅肺证患者的预后可能较痰浊阻肺证患者更差。 相似文献
3.
4.
Moderate sedatives have been increasingly used to improve patient comfort during flexible bronchoscopy (FB). However, routine use of moderate sedation during FB is controversial because its efficacy and safety are not well established.This study aims to evaluate the efficacy and safety of moderate sedation during FB.A search was made of Medline, EMBASE, and the Cochrane Library to May 2014.Randomized controlled trials (RCTs) and quasi-RCTs were included.The main analysis was designed to examine the efficacy of moderate sedation during FB in sedation than no-sedation.The willingness to repeat FB was significantly more in sedation than no-sedation (odds ratio [OR] 2.30; 95% confidence interval [CI] 1.11–4.73; P = 0.02; I2 = 22.5). The duration of FB was shorter in sedation group than no-sedation group (standardized mean difference [SMD] −0.21; 95% CI −0.38 to −0.03; P = 0.02; I2 = 78.3%). Event of hypoxia was not significantly different between sedation and no-sedation groups (OR 0.86; 95% CI 0.42–1.73; P = 0.67; I2 = 0%). The SpO2 during procedure was not different between sedation and no-sedation groups (SMD −0.14; 95% CI −0.37 to 0.08; P = 0.21; I2 = 49.9%). However, in subgroup analysis without supplemental oxygen, the SpO2 was significantly lower in sedation than no-sedation group (SMD −0.45; 95% CI −0.78 to −0.11; P = 0.01; I2 = 0.0%).According to this meta-analysis, moderate sedation in FB would be useful in patients who will require repeated bronchoscopies as well as safe in respiratory depression. To our knowledge, although the various sedative drugs are already used in the real field, this analysis was the first attempt to quantify objective results. We anticipate more definite and studies designed to elucidate standardized outcomes for moderate sedation in FB. 相似文献
5.
Hyun Jong Choi Jong Ho Moon Yun Nah Lee Hyun Su Kim Ji Su Ha Tae Hoon Lee Sang‐Woo Cha Young Deok Cho Sang‐Heum Park 《Digestive endoscopy》2015,27(7):772-775
Direct peroral cholangioscopy (POC) using an ultra‐slim upper endoscope is one modality of POC for intraductal endoscopic evaluation and treatment of the bile duct. Choledochoduodenostomy (CDS) is one modality of biliary bypass surgery that provides a new route to the bile duct. We carried out direct POC using an ultra‐slim upper endoscope without the use of accessories in 10 patients (four sump syndromes, three bile duct strictures and three intrahepatic duct stones) previously undergoing surgical CDS. Direct POC was successful in all patients. The use of an intraductal balloon catheter was required in one patient for advancement of the endoscope into the bile duct. Distal bile ducts with sump syndromes were cleared using baskets and water irrigation under direct POC. Cholangiocarcinoma was diagnosed in one patient with hilar bile duct stricture after cholangioscopic evaluation and a targeting forceps biopsy under direct POC. Intrahepatic duct stones were successfully extracted after intraductal fragmentation under direct POC. Oozing bleeding occurred during intraductal lithotripsy but stopped spontaneously. Direct POC using an ultra‐slim upper endoscope without the assistance of accessories can easily be carried out in patients undergoing CDS. 相似文献
6.
7.
8.
9.
Richard Kim Elaine Tan Emily Wang Amit Mahipal Dung-Tsa Chen Biwei Cao Fadzai Masawi Cindy Machado James Yu Dae Won Kim 《The oncologist》2020,25(12):e1893-e1899
Lessons Learned
- The combination of trametinib and sorafenib has an acceptable safety profile, albeit at doses lower than approved for monotherapy.
- Maximum tolerated dose is trametinib 1.5 mg daily and sorafenib 200 mg twice daily.
- The limited anticancer activity observed in this unselected patient population does not support further exploration of trametinib plus sorafenib in patients with hepatocellular carcinoma.
10.